Research and Markets: This Sun Pharmaceuticals Industries Ltd Company Analysis Offers Key Financial Data Ratio and SWOT Analysis

Business Wire, Dec 6, 2007

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76548) has announced the addition of "Company Analysis - Sun Pharmaceuticals Industries Ltd." to their offering.

Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.

The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.

The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.

Report Highlights

- Provides a comprehensive version of the company's performance

- Offers key financial data, ratio and SWOT analysis

- Tracks major M&A trends and developments

- Business Profile, SWOT analysis and financial information on top five competitors

- View on the company by our analysts

- Supplemented with graphs and tabular information wherever necessary

1. Company Overview

1.1 History

1.2 Business Overview

1.3 Organizational Structure

1.4 Ticker Codes at various Stock Exchange Listings

1.5 Major Mergers & Acquisitions

1.6 Management Profile

2. Product & Services

2.1 Product & Services - An Overview

2.2 Revenue & Income Summary by Business Segment

2.3 Revenue & Income Summary by Geographical Distribution

3. Financial Information for the Fiscal Year

3.1 Financial Summary

3.2 Breakup of Revenue & Sales Trends

3.3 Ratio & Market Indicators

3.4 Earning & Income Estimates

4. SWOT Analysis

4.1 Strength

4.2 Weaknesses

4.3 Opportunity

4.4 Threats

5. Top Competitors (Key Financials & SWOT Analysis)

5.1 Dr. Reddy's Laboratories Limited

5.2 Zydus Cadila Healthcare Limited

5.3 Lupin Limited

5.4 Nicholas Piramal India Limited

5.5 Wockhardt Limited

6. Analyst View

List of Tables

Table 1 1: Sun Pharmaceutical Industries Ltd. - Ticker Codes at various Stock Exchanges

Table 1 2: Sun Pharmaceutical Industries Ltd. - Major Mergers & Acquisitions (1996 to 2007)

Table 1 3: Sun Pharmaceutical Industries Ltd. - Key Management People

Table 3 1: Sun Pharmaceutical Industries Ltd. - Financial Overview (in Million Rs), March 2006

Table 3 2: Sun Pharmaceutical Industries Ltd. - Breakup of Operating Revenue & Sales (in Million Rs), March 2004 to March 2006

Table 3 3: Sun Pharmaceutical Industries Ltd. - Key Financial Ratios (March 2004 to March 2006)

Table 3 4: Sun Pharmaceutical Industries Ltd. - Earning & Income Estimates (in Thousand Rs), March 2004 to March 2006

Table 5 1: Dr. Reddy's Laboratories Limited - Key Financials (in Million Rs), March 2005 to March 2007

Table 5 2: Dr. Reddy's Laboratories Limited - SWOT Analysis

Table 5 3: Zydus Cadila Healthcare Limited - Key Financials (in Million Rs), March 2004 to March 2006

Table 5 4: Zydus Cadila Healthcare Limited - SWOT Analysis

Table 5 5: Lupin Limited - Key Financials (in Million Rs), March 2005 to March 2007

Table 5 6: Lupin Limited - SWOT Analysis

Table 5 7: Nicholas Piramal India Limited - Key Financials (in Million Rs), 2005-06 & 2006-07

Table 5 8: Nicholas Piramal India Limited - SWOT Analysis

Table 5 9: Wockhardt Limited - Key Financials (in Million Rs), 2005 & 2006

Table 5 10: Wockhardt Limited - SWOT Analysis

List of Figures

Figure 2 1: Sun Pharmaceutical Industries Ltd. - Revenue by Business Segment (in Million Rs), March 2006 & March 2007

Figure 2 2: Sun Pharmaceutical Industries Ltd. - Revenue by Geographical Distribution (in Million Rs), March 2006 & March 2007

For more information visit http://www.researchandmarkets.com/reports/c76548.>

COPYRIGHT 2007 Business Wire

COPYRIGHT 2008 Gale, Cengage Learning